Collegium Pharmaceutical, Inc. (COLL) Operating income 2016–2025
Collegium Pharmaceutical, Inc. (COLL) annual operating income history from SEC filings — each fiscal year as reported.
$179.6MFY2025 · since FY2016: -$94.1M → $179.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $179.6M | +5.7% |
| FY2024 | $169.9M | +1.8% |
| FY2023 | $167.0M | +401.1% |
| FY2022 | $33.3M | +89.0% |
| FY2021 | $17.6M | -68.7% |
| FY2020 | $56.2M | +336.8% |
| FY2019 | -$23.7M | -14.8% |
| FY2018 | -$20.7M | +72.6% |
| FY2017 | -$75.4M | +19.8% |
| FY2016 | -$94.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice